Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The MiniMed™ 780G Glycemic Control and Quality of Life Study for the Treatment of Pediatric and Adult Subjects With Type 1 Diabetes in France (EQOL Study)

NCT04308291 is registered in ClinicalTrials.gov with Medtronic MiniMed, Inc. as lead sponsor.

NCT NCT04308291
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04308291 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The MiniMed™ 780G Glycemic Control and Quality of Life Study for the Treatment of Pediatric and Adult Subjects With Type 1 Diabetes in France (EQOL Study)
Lead sponsor
Medtronic MiniMed, Inc.
Phase
Observational
Overall status
Completed
Start date
February 15, 2021
Completion date
October 27, 2022
Enrollment
306 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes